Advancing medicines
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical therapeutic problems and meaningfully improve people’s lives. We apply innovative drug delivery technology and scientific expertise to redesign important medicines. Our initial focus, supported by our current approved products and late stage pipeline, is to improve medications and outcomes for patients with central nervous system (CNS) conditions.
Our success is proven
2
Billion PharmFilm doses consumed by patients
200+
Worldwide patents
4
Continents where our products are sold
Latest news
-
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZANTM (clobazam) Oral Film
SYMPAZAN is the first and only FDA-approved oral film formulation of clobazam, a benzodiazepine approved for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients ...
-
Aquestive Therapeutics Announces Tentative FDA Approval for SympazanTM (clobazam) Oral Film
Sympazan is an oral soluble film formulation of clobazam, a benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients 2 years of age or ol...
NOW APPROVED
The first and only FDA approved film formulation of clobazam.
Click here to learn more Please see full prescribing information, including BOXED WARNING